N@N

BIOLASE Granted Canadian Approval to Sell iLase(TM) Personal Dental Laser Systems

^{Published on 2010-06-11 03:40:13 - Market Wire}
 

IRVINE, CA--(Marketwire - June 11, 2010) - BIOLASE Technology, Inc. (NASDAQ: [ BLTI ]), the world's leading dental laser company, announced today that it has received approval from Health Canada-Medical Device Bureau to sell its iLase™ personal dental laser systems throughout Canada. Canada has an estimated 19,000 licensed dentists and an equivalent number of hygienists.

The iLase diode laser is the world's first personal laser for dentists and hygienists for performing a full-range of minimally invasive soft-tissue and hygiene procedures. It is also the first completely self-contained, hand-held dental laser that includes the laser, user interface, battery power, and controls in a single, integrated handpiece with no foot pedals or cords.

Chief Executive Officer David M. Mulder said, "This approval is significant in expanding the market for this revolutionary new product. The response to the iLase has been overwhelming. A key byproduct of the iLase is its importance in drawing attention to the potential of pain-free laser dentistry, its ease of use and clinically superior results. The iLase is already proving its value for our sales team as they introduce and demonstrate our laser technology as essential tools in dentistry to new potential customers around the world."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at [ http://www.biolase.com ], Twitter at [ http://twitter.com/GoWaterlase ], Facebook at [ http://facebook.com/biolase ], and YouTube at [ http://www.youtube.com/user/Rossca08 ].

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.